Shenzhen Lifotronic Technology Co Ltd is a China-based company mainly engaged in the research, development, manufacturing and marketing of medical devices. The Company focuses on the development and technological innovation of treatment and rehabilitation equipment, in vitro diagnostic equipment and supporting detection reagents. The Company's products mainly include wound and skin treatment products, perioperative and intensive care products, pain and rehabilitation treatment products and in vitro diagnostic products. The Company mainly conducts its businesses in domestic and overseas markets.

Employees

1,481

Sector

Medical Equipment, Supplies & Distribution

Calendar

20/10/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
13/09/24	13.00 ¥	-2.99%	3,245,288
12/09/24	13.40 ¥	-1.54%	5,112,112
11/09/24	13.61 ¥	+5.10%	9,013,402
10/09/24	12.95 ¥	+1.33%	3,528,766
09/09/24	12.78 ¥	+0.47%	5,564,499

End-of-day quote Shanghai S.E., September 12, 2024

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

4

Last Close Price

13.00CNY

Average target price

20.87CNY

Spread / Average Target

+60.56%

Consensus

Profit revisions

Estimate revisions

Annual profits - Rate of surprise

Company calendar

End-of-day quote Shanghai S.E. Other stock markets 13/09/2024			5-day change	1st Jan Change
13.00 ^CNY	-2.99%		+2.20%	-42.25%

09-11	Lifotronic Technology to Buy Stake in Medical Equipment Maker Through 16 Million Yuan Capital Injection; Shares Up 5%	MT
09-09	Sichuan Anjie Changhe Medical Technology Co., Ltd announced that it expects to receive CNY 39 million in funding from Shenzhen Lifotronic Technology Co., Ltd. and another investor	CI

Capitalization	5.57B 786M 59.84B	P/E ratio 2024 *	13.4x	P/E ratio 2025 *	10.8x
Enterprise value	9.6B 1.35B 103B	EV / Sales 2024 *	4.01x	EV / Sales 2025 *	3.26x
Free-Float	45.76%	Yield 2024 *	2.54%	Yield 2025 *	3%

Lifotronic Technology to Buy Stake in Medical Equipment Maker Through 16 Million Yuan Capital Injection; Shares Up 5%	09-11	MT
Sichuan Anjie Changhe Medical Technology Co., Ltd announced that it expects to receive CNY 39 million in funding from Shenzhen Lifotronic Technology Co., Ltd. and another investor	09-08	CI
Shenzhen Lifotronic Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	08-27	CI
Chengdu Anjiechang Medical Technology Co., Ltd. announced that it expects to receive CNY 39 million in funding from Shenzhen Lifotronic Technology Co., Ltd. and another investor	08-25	CI
Lifotronic Technology to Build Industrial Base for 1 Billion Yuan; Shares Up 4%	06-26	MT
Shenzhen Lifotronic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-22	CI
Shenzhen Lifotronic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23	CI
Shenzhen Lifotronic Biotechnology Co., Ltd. announced that it expects to receive CNY 97.02 million in funding from Shenzhen Lifotronic Technology Co., Ltd. and other investors.	23/10/23	CI
Shenzhen Lifotronic Technology Co., Ltd.(XSSC:688389) added to S&P Global BMI Index	18/09/23	CI
Shenzhen Lifotronic Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23	CI

1 day	-2.99%
1 week	+2.20%
Current month	-3.35%
1 month	-15.42%
3 months	-29.19%
6 months	-32.61%
Current year	-42.25%

Shenzhen Lifotronic Technology Co., Ltd. Share Price

Equities

688389

CNE100005WZ5

Medical Equipment, Supplies & Distribution

Valuation: Shenzhen Lifotronic Technology Co., Ltd.

Chart: Shenzhen Lifotronic Technology Co., Ltd.

Latest news: Shenzhen Lifotronic Technology Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: Shenzhen Lifotronic Technology Co., Ltd.

Diagnostic & Testing Substances

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Annual profits - Rate of surprise

Director	Title	Age	Since
Ming Long Hu CEO	Chief Executive Officer	55	31/12/13
Min Liu CHM	Chairman	55	31/12/07
Hong Wang DFI	Director of Finance/CFO	58	31/12/10

Manager	Title	Age	Since
Xian Cheng Liu FOU	Founder	56	15/01/08
Ming Long Hu CEO	Chief Executive Officer	55	31/12/13
Ying Zeng BRD	Director/Board Member	55	31/12/12

	2024 *	2025 *
Net sales	1.39B 196M 14.94B	1.71B 241M 18.33B
Net income	415M 58.5M 4.46B	517M 72.95M 5.56B
Net Debt	-	-

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.	-2.99%	+2.20%	-37.44%	-29.23%	785M
BIOMÉRIEUX	-0.09%	+4.26%	+20.28%	+0.96%	14.41B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+0.62%	+3.23%	+10.88%	+52.14%	7.69B
LANTHEUS HOLDINGS, INC.	+1.46%	+3.50%	+69.15%	+321.02%	7.33B
DIASORIN S.P.A.	+1.91%	+2.82%	+13.44%	-47.13%	6.15B
VITROLIFE AB	-1.27%	-2.06%	+89.59%	-51.88%	3.29B
AUTOBIO DIAGNOSTICS CO., LTD.	-0.83%	-4.10%	-16.45%	-23.96%	3.12B
10X GENOMICS, INC.	-0.80%	+3.85%	-54.15%	-86.76%	2.7B
ANDON HEALTH CO., LTD.	-1.87%	-5.37%	+9.98%	+459.36%	2.62B
MYRIAD GENETICS, INC.	+4.55%	+2.30%	+72.44%	-15.63%	2.51B
Average	+0.07%	+1.16%	+17.77%	+57.89%	5.06B
Weighted average by Cap.	+0.42%	+2.28%	+24.53%	+62.08%